
Gene knockout cell lines are generated using CRISPR-Cas9 based technology to precisely disrupt target genes, enabling functional genomics research, disease modeling, and target validation.
ZZEF1 (zinc finger ZZ-type and EF-hand domain containing 1) encodes a multidomain protein with zinc finger and EF-hand regions and predicted histone reader activity. ZZEF1 can bind lysine-acetylated and methylated histones, suggesting a role in recognition of chromatin-associated modifications. It has also been implicated in processes related to synaptic transmission, regulation of protein phosphorylation, and visual learning. Its predicted localization at neuronal pre- and postsynaptic structures suggests potential functions in neuronal signaling and synaptic organization.
A human hepatocellular carcinoma cell line of Japanese origin, established from the liver tumor of a 57-year-old male patient. The cells are classified as an adult hepatocellular carcinoma line and have been extensively characterized for their molecular and genetic properties. The cell line exhibits a predominantly East Asian genomic ancestry profile and carries documented sequence variations affecting genes including KDR, POLD3, TERT, and TP53.
Comprehensive quality control includes STR authentication, sterility testing (bacteria and fungi), and mycoplasma screening to ensure purity and performance. Genotype is confirmed by two rounds of PCR and Sanger sequencing, and complete validation reports are provided for make-to-order products.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Targeted knockout region: EExon 1
Reference Transcript: NM_015113
Frameshift Mutation Strategy
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use





Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?